Main Session
Sep
28
PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology
2789 - Crizotinib Induction Followed by CHOP-Based Chemotherapy and Consolidative ISRT in a "Sandwich" Strategy for Bulky ALK-Positive Anaplastic Large Cell Lymphoma
Presenter(s)
Tao Liu, - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, Wuhan,